#BEGIN_DRUGCARD DB03185

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C10H14N2O5

# Chemical_IUPAC_Name:
1-[(2R,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,3-dihydro-1H-1,3-diazepin-2-one

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
1-Beta-Ribofuranosyl-1,3-Diazepinone

# HET_ID:
BRD

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C10H14N2O5/c13-5-6-7(14)8(15)9(17-6)12-4-2-1-3-11-10(12)16/h1-4,6-9,13-15H,5H2,(H,11,16)/t6-,7-,8+,9+/m0/s1

# InChI_Key:
InChIKey=MEPCJRCEYSZBDO-RBXMUDONSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3185

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
242.2286

# Molecular_Weight_Mono:
242.090271568

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1MQ0

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.4

# Predicted_LogS:
-0.12

# Predicted_Water_Solubility:
1.83e+02 g/l

# Primary_Accession_No:
DB03185

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936597

# PubChem_Substance_ID:
46505407

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00750

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC[C@@H]1O[C@H]([C@H](O)[C@H]1O)N1C=CC=CNC1=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:00 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Phase_1_Metabolizing_Enzyme_1_Gene_Name:
CDA

# Phase_1_Metabolizing_Enzyme_1_ID:
4211

# Phase_1_Metabolizing_Enzyme_1_Name:
Cytidine deaminase

# Phase_1_Metabolizing_Enzyme_1_Protein_Sequence:
>Cytidine deaminase
MAQKRPACTLKPECVQQLLVCSQEAKKSAYCPYSHFPVGAALLTQEGRIFKGCNIENACY
PLGICAERTAIQKAVSEGYKDFRAIAIASDMQDDFISPCGACRQVMREFGTNWPVYMTKP
DGTYIVMTVQELLPSSFGPEDLQKTQ

# Phase_1_Metabolizing_Enzyme_1_SwissProt_ID:
P32320

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
CDA

# Drug_Target_1_GenBank_ID_Gene:
L27943

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
CDA

# Drug_Target_1_Gene_Sequence:
>441 bp
ATGGCCCAGAAGCGTCCTGCCTGCACCCTGAAGCCTGAGTGTGTCCAGCAGCTGCTGGTT
TGCTCCCAGGAGGCCAAGAAGTCAGCCTACTGCCCCTACAGTCACTTTCCTGTGGGGGCT
GCCCTGCTCACCCAGGAGGGGAGAATCTTCAAAGGGTGCAACATAGAAAATGCCTGCTAC
CCGCTGGGCATCTGTGCTGAACGGACCGCTATCCAGAAGGCCGTCTCAGAAGGGTACAAG
GATTTCAGGGCAATTGCTATCGCCAGTGACATGCAAGATGATTTTATCTCTCCATGTGGG
GCCTGCAGGCAAGTCATGAGAGAGTTTGGCACCAACTGGCCCGTGTACATGACCAAGCCG
GATGGTACGTATATTGTCATGACGGTCCAGGAGCTGCTGCCCTCCTCCTTTGGGCCTGAG
GACCTGCAGAAGACTCAGTGA

# Drug_Target_1_General_Function:
Involved in zinc ion binding

# Drug_Target_1_General_References:
7923172	Laliberte J, Momparler RL: Human cytidine deaminase: purification of enzyme, cloning, and expression of its complementary DNA. Cancer Res. 1994 Oct 15;54(20):5401-7.
8422236	Kuhn K, Bertling WM, Emmrich F: Cloning of a functional cDNA for human cytidine deaminase (CDD) and its use as a marker of monocyte/macrophage differentiation. Biochem Biophys Res Commun. 1993 Jan 15;190(1):1-7.
9596658	Gran C, Boyum A, Johansen RF, Lovhaug D, Seeberg EC: Growth inhibition of granulocyte-macrophage colony-forming cells by human cytidine deaminase requires the catalytic function of the protein. Blood. 1998 Jun 1;91(11):4127-35.
9878810	Demontis S, Terao M, Brivio M, Zanotta S, Bruschi M, Garattini E: Isolation and characterization of the gene coding for human cytidine deaminase. Biochim Biophys Acta. 1998 Dec 22;1443(3):323-33.

# Drug_Target_1_HGNC_ID:
HGNC:1712

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
4211

# Drug_Target_1_Locus:
1p36.2-p35

# Drug_Target_1_Molecular_Weight:
16185

# Drug_Target_1_Name:
Cytidine deaminase

# Drug_Target_1_Number_of_Residues:
146

# Drug_Target_1_PDB_ID:
1MQ0

# Drug_Target_1_Pathway:
Capecitabine Pathway	SMP00469

# Drug_Target_1_Pfam_Domain_Function:
PF00383	dCMP_cyt_deam_1

# Drug_Target_1_Protein_Sequence:
>Cytidine deaminase
MAQKRPACTLKPECVQQLLVCSQEAKKSAYCPYSHFPVGAALLTQEGRIFKGCNIENACY
PLGICAERTAIQKAVSEGYKDFRAIAIASDMQDDFISPCGACRQVMREFGTNWPVYMTKP
DGTYIVMTVQELLPSSFGPEDLQKTQ

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
This enzyme scavenge exogenous and endogenous cytidine and 2'-deoxycytidine for UMP synthesis

# Drug_Target_1_SwissProt_ID:
P32320

# Drug_Target_1_SwissProt_Name:
CDD_HUMAN

# Drug_Target_1_Synonyms:
Cytidine aminohydrolase
EC 3.5.4.5

# Drug_Target_1_Theoretical_pI:
6.95

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03185
